Effectiveness of MF59 (TM) Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands
Background: The aim of the present study was to estimate the effectiveness of the MF59 (TM)-adjuvanted influenza A(H1N1)pdm09 vaccine against medically attended influenza-like illness and RT-PCR confirmed influenza in the at-risk population and persons over 60 in the Netherlands. Methods: We conducted a retrospective cohort study in a Dutch based GP medical record database between 30 November 2009 and 1 March 2010 to estimate the vaccine effectiveness against influenza-like illness. Within the cohort we nested a test negative case-control study to estimate the effectiveness against laboratory... Mehr ...
Verfasser: |
Wijnans, L
Dieleman, Jeanne
Voordouw, B
Sturkenboom, MCJM |
Dokumenttyp: |
Artikel |
Erscheinungsdatum: |
2013 |
Reihe/Periodikum: |
Wijnans , L , Dieleman , J , Voordouw , B & Sturkenboom , MCJM 2013 , ' Effectiveness of MF59 (TM) Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands ' , PLoS One (print) , vol. 8 , no. 4 . https://doi.org/10.1371/journal.pone.0063156 |
Schlagwörter: |
/dk/atira/pure/keywords/researchprograms/AFL001000/EMCCOEUR09
/ name=EMC COEUR-09
/ /dk/atira/pure/keywords/researchprograms/AFL001000/EMCNIHES037702
/ name=EMC NIHES-03-77-02
/ /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
/ name=SDG 3 - Good Health and Well-being |
Sprache: |
unknown |
Permalink: |
https://search.fid-benelux.de/Record/base-28793995 |
Datenquelle: |
BASE;
Originalkatalog |
Powered By: |
BASE |
Link(s) :
|
https://pure.eur.nl/en/publications/17564ce1-c27c-4013-8e03-8c2acdb816d7 |